两组分尖尖纳米粒子疫苗可以保护免受SARS-CoV-2感染
Philip J M Brouwer1, Mitch Brinkkemper1, Pauline Maisonnasse2
1Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam Infection & Immunity Institute, 1105 AZ Amsterdam, the Netherlands.
Cell
|February 12, 2021
概括
一种基于蛋白质的新型纳米粒子疫苗显示了SARS-CoV-2尖端蛋白质,在动物模型中有效产生了强大的中和抗体. 这种候选疫苗在非人类灵长类动物中对严重急性呼吸综合征冠状病毒 2 挑战进行了保护.
科学领域:
- 病毒学
- 免疫学
- 疫苗开发
背景情况:
- 严重急性呼吸系统综合征冠状病毒2 (SARS-CoV-2) 流行病造成了广泛的干扰,需要有效的疫苗.
- 目前的疫苗策略旨在预防病毒感染,传播和疾病的进展.
研究的目的:
- 开发和评估一种新的基于蛋白质的纳米粒子疫苗,该疫苗显示了SARS-CoV-2尖端蛋白的多个副本.
- 评估这个纳米粒子候选疫苗的免疫性和保护性.
主要方法:
- 一种基于蛋白质的两组分纳米粒子疫苗被设计成显示SARS-CoV-2尖端蛋白.
- 对小鼠,和进行了免疫研究.
- 通过对受保护的进行高剂量SARS-CoV-2挑战来评估疫苗的有效性.
主要成果:
- 在所有测试的动物模型中,纳米粒子疫苗诱导了强烈的中和抗体反应.
- 接种疫苗的对高剂量SARS-CoV-2的挑战有显著的保护作用.
- 在受保护的中观察到上下呼吸道病毒感染和复制的减少.
结论:
- 开发的基于蛋白质的纳米粒子疫苗是控制SARS-CoV-2流行病的有希望的候选者.
- 这种疫苗会引起强烈的免疫反应,并为抗病毒提供显著的保护.
- 这种纳米粒子疫苗平台的进一步开发可能有助于对抗当前和未来的冠状病毒疫情.
更多相关视频
08:07A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain
Published on: July 25, 2022
2.8K
08:07Author Spotlight: Advancing Antiviral Strategies Through Novel Immunocapture and Mass Spectrometry Techniques
Published on: January 12, 2024
1.0K
相关概念视频
02:50Conjugated Proteins
29.8K
Simple proteins and protein complexes contain only amino acids. In contrast, many other proteins, called conjugated proteins, covalently bond with non-protein moieties.
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
29.8K
01:21Vaccines
51
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the...
51